Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03294707 · ClinicalTrials.gov registry record · Phase 1
Single and Multiple Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of AG10
A Phase 1 study, sponsored by Eidos Therapeutics, a BridgeBio company.
- Completed
- Registry status
- Phase 1
- Development phase
- 56
- Enrollment target
NCT03294707: Completed Phase 1 study, sponsored by Eidos Therapeutics, a BridgeBio company.
NCT03294707 is a Phase 1 study that has completed, run by Eidos Therapeutics, a BridgeBio company. The registered enrollment target is 56 participants, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03294707, a Phase 1 study, has completed, sponsored by Eidos Therapeutics, a BridgeBio company.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 56 participants
- Enrollment target
Study Summary
This is a single center, prospective, randomized, placebo-controlled study of AG10 in healthy adult subjects
Primary Outcome
To evaluate the safety and tolerability of single and multiple doses of AG10 administered to healthy adult subjects
Interventions
- DRUG Placebo Oral Tablet
- DRUG AG10 oral tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2017-09-11 |
| Est. Completion | 2018-05-18 |
| Phase | Phase 1 |
What the finished NCT03294707 record still lists
NCT03294707 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Placebo Oral Tablet is the first listed.
NCT03294707 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03294707 about?
NCT03294707 is a clinical study titled "Single and Multiple Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of AG10". This is a single center, prospective, randomized, placebo-controlled study of AG10 in healthy adult subjects
What is the current status of trial NCT03294707?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 56 participants. The study started on 2017-09-11. Estimated completion is 2018-05-18.
What interventions are being tested in trial NCT03294707?
The interventions under investigation include: Placebo Oral Tablet (DRUG), AG10 oral tablet (DRUG).
Who is sponsoring clinical trial NCT03294707?
This trial is sponsored by Eidos Therapeutics, a BridgeBio company, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03294707's enrollment target sits among peer trials
56 902nd of 2000 higher than 1,083 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI